5.08 -0.20 (-3.77%)
SPPI
Stock Details
Last Trade:5.08 Change:-0.20 (-3.77%) Prev Close:5.28 Open: 5.30 Days Range:5.06 – 5.32 52 Week Range: 1.42 - 10.00 Volume:645311 P/E: N/AEPS:-0.73
View AllRecent Alerts 03/19/10
Recent Alert on 02/16/10 at 8:45am
Celldex Therapeutics (CLDX) Receives $3M Sublicense Income From Belinostat Co-Development
Celldex Therapeutics (CLDX) Receives $3M Sublicense Income From Belinostat Co-Development
Celldex Therapeutics, Inc. (NASDAQ: CLDX) today announced that it has received a sublicense income payment of $3 million from TopoTarget A/S as a result of the recent co-development and commercialization agreement between TopoTarget and Spectrum... Read More
Recent Alert on 02/02/10 at 7:33am
TopoTarget and Spectrum Pharmaceuticals (SPPI) In Deal To Commercialize Belinostat in North America and India
TopoTarget and Spectrum Pharmaceuticals (SPPI) In Deal To Commercialize Belinostat in North America and India
Recent Alert on 02/02/10 at 7:33am
TopoTarget and Spectrum Pharmaceuticals (SPPI) In Deal To Commercialize Belinostat in North America and India
TopoTarget and Spectrum Pharmaceuticals (SPPI) In Deal To Commercialize Belinostat in North America and India
Recent Alert on 02/01/10 at 9:33am
Morgan Joseph Adds Spectrum Pharmaceuticals (SPPI) to Trading List; Expect Strong Growth From Zevalin
Morgan Joseph Adds Spectrum Pharmaceuticals (SPPI) to Trading List; Expect Strong Growth From Zevalin
Recent Alert on 01/25/10 at 7:29am
Spectrum Pharma (SPPI) Meets with U.S. FDA for FUSILEV; FDA is Requesting More Data, No More Efficacy Studies
Spectrum Pharma (SPPI) Meets with U.S. FDA for FUSILEV; FDA is Requesting More Data, No More Efficacy Studies
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
No Recent SEC Filings Available